A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine
Public ClinicalTrials.gov record NCT00735475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV, Randomized, Observer-Blind, Multi-Center, Non Inferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Inactivated Split-Virion Influenza Vaccine in Adults Aged Greater Than or Equal to 65 Years
Study identification
- NCT ID
- NCT00735475
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Seqirus
- Industry
- Enrollment
- 1,268 participants
Conditions and interventions
Conditions
Interventions
- CSL Limited Influenza Virus Vaccine (Afluria®) Biological
- US Licensed Influenza Virus Vaccine (Fluzone®) Biological
Biological
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2008
- Primary completion
- Dec 31, 2008
- Completion
- May 31, 2009
- Last update posted
- May 22, 2018
2008 – 2009
United States locations
- U.S. sites
- 13
- U.S. states
- 13
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Central Arkansas Medical Association | Mountain Home | Arkansas | 72635 | — |
| Covance CRU, Inc | Boise | Idaho | 83704 | — |
| The University of Iowa | Iowa City | Iowa | 52242 | — |
| Kentucky Pediatric/ Adult Research | Bardstown | Kentucky | 40004 | — |
| Saint Louis University Medical Center | St Louis | Missouri | 63104 | — |
| University of Rochester School of Medicine and Dentistry | Rochester | New York | 14642 | — |
| Duke University Medical Center | Durham | North Carolina | 27704 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Covance CRU, Inc. | Portland | Oregon | 97239 | — |
| Primary Physicians Research, Inc. | Pittsburgh | Pennsylvania | 15241 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Vanderbilt Medical Center | Nashville | Tennessee | 37232 | — |
| Covance CRU Inc. | Austin | Texas | 78752 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00735475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00735475 live on ClinicalTrials.gov.